ScholarIQanswers from OpenAlex
Pharmacology and Obesity Treatment
TopicLeading institutions, researchers & key papers
Pharmacology and Obesity Treatment is a topic indexed in ScholarIQ from OpenAlex.
What is known about Pharmacology and Obesity Treatment?
ScholarIQrecord summary
This cluster of papers focuses on the pharmacological management of obesity, including the use of anti-obesity drugs, clinical trials evaluating their efficacy and safety, and the impact on weight loss. It covers a wide range of medications such as sibutramine, orlistat, and ephedra alkaloids, as well as their associated adverse events and lipase inhibitors.
How many works does Pharmacology and Obesity Treatment have?
ScholarIQindexed works
Pharmacology and Obesity Treatment has 210 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Pharmacology and Obesity Treatment?
ScholarIQopenalex
The OpenAlex for Pharmacology and Obesity Treatment is on the source record.
What are the most-cited papers on Pharmacology and Obesity Treatment?
ScholarIQmost cited works
Valvular Heart Disease Associated with Fenfluramine–Phentermine
Heidi M. Connolly, Jack L. Crary, Michael D. McGoon, Donald D. Hensrud, Brooks S. Edwards, William D. Edwards, Hartzell V. Schaff
Obesity in adults: a clinical practice guideline
Sean Wharton, David C.W. Lau, Michael Vallis, Arya M. Sharma, Laurent Biertho, Denise Campbell‐Scherer, Kristi B. Adamo, Angela S. Alberga, Rhonda C. Bell, Normand G. Boulé, Elaine Boyling, Jennifer Brown, Betty Calam, Carol Clarke, Lindsay Crowshoe, Dennis DiValentino, Mary Forhan, Yoni Freedhoff, Michel Gagner, Stephen Glazer, C. G. Grand, Michael Green, Margaret Hahn, Raed Hawa, Rita Henderson, Dennis Hong, Pam Hung, Ian Janssen, Kristen Jacklin, Carlene Johnson Stoklossa, Amy Kemp, Sara Kirk, Jennifer L. Kuk, Marie‐France Langlois, Scott A. Lear, Ashley McInnes, David Macklin, Leen Naji, Priya Manjoo, Marie‐Philippe Morin, Kara Nerenberg, Ian Patton, Sue D. Pedersen, Leticia Pereira, Helena Piccinini‐Vallis, Megha Poddar, Paul Poirier, Denis Prud’homme, Ximena Ramos Salas, Christian F. Rueda‐Clausen, Shelly Russell‐Mayhew, Judy Shiau, Diana Sherifali, John L. Sievenpiper, Sanjeev Sockalingam, Valerie H. Taylor, Ellen L. Toth, Laurie Twells, Richard Tytus, Shahebina Walji, Leah Walker, Sonja Wicklum
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Caroline M. Apovian, Louis J. Aronne, Daniel H. Bessesen, Marie E. McDonnell, M. Hassan Murad, Uberto Pagotto, Donna H. Ryan, Christopher D. Still
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Kishore M. Gadde, David B. Allison, Donna H. Ryan, Craig A. Peterson, Barbara Troupin, Michael Schwiers, Wesley Day
Management of obesity
George A. Bray, Gema Frühbeck, Donna H. Ryan, John Wilding
Where is Pharmacology and Obesity Treatment research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Pharmacology and Obesity Treatment is open access?
ScholarIQopen access share
47%OPEN ACCESS